Intranasal Drug Delivery Devices Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Intranasal Drug Delivery Devices market size was valued at USD 1176.1 million in 2022 and is forecast to a readjusted size of USD 2369.8 million by 2029 with a CAGR of 10.5% during review period.

Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.

North America is the largest region of Intranasal Drug Delivery Devices, with a market share about 40%. It was followed by Europe with 35%. BD, AptarGroup, 3M Company, Teleflex, H&T Presspart and Bespak are the top 6 manufacturers of industry, and they had about 85% combined market share.

This report is a detailed and comprehensive analysis for global Intranasal Drug Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Intranasal Drug Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Intranasal Drug Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Intranasal Drug Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Intranasal Drug Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intranasal Drug Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Intranasal Drug Delivery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   BD
   AptarGroup
   3M
   Teleflex
   H＆T Presspart
   Bespak
 

   Multidose
   Uni/bidose

   Personal Use
   Hospital Use
 

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the intranasal drug delivery devices market in 2025?

The strengths of the intranasal drug delivery devices market include the non-invasive nature of the method, which enhances patient compliance, especially in pediatric and geriatric populations. Additionally, the rapid absorption of drugs through the nasal mucosa leads to faster onset of action. The growing demand for personalized medicine and the expansion of biotechnology also contribute to market growth.

What weaknesses could affect the market's growth?

Some weaknesses include challenges related to device consistency and accuracy in drug delivery. There is also the risk of irritation or damage to the nasal passage, which may limit long-term use. Furthermore, the need for regular maintenance and cleaning of devices can be seen as a hurdle. Regulatory hurdles and the relatively high costs of developing and commercializing new intranasal products can be limiting factors.

What opportunities exist for the intranasal drug delivery devices market?

Opportunities in the market include the potential for new drug formulations and applications, particularly in the treatment of chronic diseases like diabetes, migraines, and Parkinson’s disease. The increasing interest in vaccines and biologics delivered intranasally also presents new avenues for growth. Additionally, the growing trend of at-home healthcare could lead to greater acceptance of intranasal devices.

What threats could impact the intranasal drug delivery devices market?

Threats include the potential for competition from other drug delivery methods, such as oral and transdermal systems, which may offer simpler or more effective solutions. There is also the risk of stringent regulatory requirements, which could delay product approval and adoption. The growing concern around device safety and possible side effects could also deter market growth, as well as the high cost of R&D in this specialized area.

How do political factors impact the intranasal drug delivery devices market in 2025?

Political factors, such as government healthcare policies and reimbursement frameworks, play a significant role in shaping market growth. If governments favor non-invasive treatment methods through policies or healthcare programs, the market could see expansion. However, political instability or changes in healthcare regulations can also introduce uncertainty, affecting market dynamics.

What economic factors influence the market?

Economic factors, including healthcare budgets, consumer spending, and the affordability of intranasal devices, impact the market. The rising costs of healthcare and treatments may push the demand for more cost-effective delivery systems. Economic recessions could lead to reduced funding for medical devices or restrict patient access to newer, more expensive intranasal treatments.

How do social factors affect the intranasal drug delivery devices market?

Social factors, such as growing awareness of non-invasive treatments and patient preference for ease of use, support the adoption of intranasal drug delivery devices. Additionally, the increasing prevalence of chronic diseases and conditions that require frequent medication could boost demand. However, cultural preferences for certain types of drug delivery may limit the widespread adoption in certain regions.

What technological advancements are influencing the market?

Technological factors have a significant impact, with advances in drug formulation, device design, and nasal delivery technology enhancing the efficacy and patient experience. Innovations in biologics and vaccines delivered intranasally could drive future growth. The integration of smart technologies, such as dose monitoring and tracking, also opens up new opportunities for more efficient treatment methods.

What environmental considerations are relevant to the market?

Environmental factors, such as sustainability concerns, are becoming more prominent in healthcare. There is growing pressure to reduce the environmental impact of medical devices, including intranasal drug delivery systems. Manufacturers may face challenges related to eco-friendly packaging, recyclability, and waste reduction, influencing both production costs and consumer perceptions.

How do legal factors affect the intranasal drug delivery devices market?

Legal factors, particularly in the form of strict regulatory requirements, heavily influence the market. The approval processes for new intranasal devices can be lengthy and costly. Additionally, compliance with safety and efficacy standards, intellectual property rights, and liability concerns play a critical role in shaping the strategies of manufacturers and developers in this space.

Who are the suppliers in the intranasal drug delivery devices market?

Suppliers in the intranasal drug delivery devices market include manufacturers of raw materials such as plastics, metals, and rubber for device construction, as well as pharmaceutical companies that provide the drugs to be delivered. Component suppliers for sensors, pumps, and nozzles, as well as research and development organizations, also play key roles in the supply chain.

What inputs are needed for the intranasal drug delivery devices market?

Inputs required include high-quality raw materials for device production, advanced technology for drug formulation, and manufacturing expertise for device assembly. Regulatory knowledge, clinical research data, and funding for R&D are also essential inputs in ensuring the safety, efficacy, and commercial success of intranasal devices.

What process steps are involved in the intranasal drug delivery devices market?

The process involves several key steps: device design and development, testing for safety and efficacy, regulatory approval, manufacturing, and commercialization. It also includes continuous monitoring of the devices' performance in clinical settings, post-market surveillance, and adaptation of devices based on user feedback and technological advancements.

Who are the customers in the intranasal drug delivery devices market?

Customers in this market include hospitals, clinics, and healthcare providers who use intranasal drug delivery systems in treatment settings. Additionally, individual patients who prefer non-invasive drug delivery methods, as well as pharmaceutical companies and biotech firms interested in utilizing intranasal routes for drug delivery, are key customer segments.

What are the outputs of the intranasal drug delivery devices market?

The outputs of this market are the intranasal devices themselves, along with the associated drug formulations and delivery systems. These outputs aim to provide patients with a convenient, effective, and non-invasive method of drug administration, particularly for conditions requiring rapid onset of action. Additionally, innovations in the devices, such as smart technologies for monitoring and tracking doses, are key outputs that enhance patient outcomes.

What is the threat of new entrants in the intranasal drug delivery devices market?

The threat of new entrants is moderate. While the market shows promise due to the growing demand for non-invasive drug delivery, the high capital investment required for R&D, manufacturing, and meeting regulatory standards can be a significant barrier. However, the increasing interest in innovative drug delivery solutions may encourage new players with specialized technologies to enter the market.

What is the bargaining power of suppliers in the intranasal drug delivery devices market?

The bargaining power of suppliers is moderate to high. Suppliers of raw materials and advanced technologies for intranasal devices hold some leverage due to the specialized nature of the components required. However, as the market expands, manufacturers may seek to diversify their supplier base, which could reduce supplier power over time.

What is the bargaining power of buyers in the intranasal drug delivery devices market?

The bargaining power of buyers is moderate. Patients, healthcare providers, and pharmaceutical companies have some influence over pricing and device features, particularly as they demand more efficient, user-friendly, and cost-effective solutions. However, due to the specialized nature of intranasal devices, the range of options available to buyers may be limited in certain therapeutic areas.

What is the threat of substitute products or services in the intranasal drug delivery devices market?

The threat of substitutes is moderate. Alternatives like oral, transdermal, and injectable drug delivery systems are commonly used and may pose competition. However, the non-invasive, rapid onset, and patient-compliant nature of intranasal devices gives them a competitive edge for certain therapeutic applications, lowering the threat from substitutes.

What is the intensity of competitive rivalry in the intranasal drug delivery devices market?

The intensity of competitive rivalry is moderate to high. With the increasing demand for non-invasive drug delivery methods, there is growing competition among established medical device companies, pharmaceutical firms, and startups. Innovations, regulatory challenges, and the need for clinical validation keep competition strong, but the market is still evolving, which provides opportunities for differentiation.

What are the key upstream factors influencing the intranasal drug delivery devices market?

Key upstream factors include the availability and cost of raw materials for device manufacturing, such as plastics, metals, and rubber. Technological advancements in drug delivery mechanisms and the development of new formulations are also crucial. Additionally, the regulatory landscape and the need for clinical trials to prove safety and efficacy are significant factors in the upstream process.

How does the supply chain affect the intranasal drug delivery devices market?

The supply chain plays a critical role in ensuring timely and cost-effective production of intranasal devices. Delays in sourcing raw materials or specialized components can affect production schedules. Supplier relationships and the reliability of component providers also impact the quality and consistency of devices. Furthermore, logistics and distribution channels are essential to ensure that devices reach healthcare providers and patients efficiently.

What role do partnerships and collaborations play in the upstream of this market?

Partnerships and collaborations are crucial in driving innovation and ensuring access to new technologies, especially for drug formulations and delivery mechanisms. Collaborations between pharmaceutical companies and medical device manufacturers help in co-developing products. Regulatory bodies also play a role in guiding these partnerships to ensure compliance with safety standards and approvals, which can influence the market's overall success.

How do regulatory requirements impact the upstream in this market?

Regulatory requirements significantly affect the upstream process, as companies must adhere to strict guidelines for manufacturing, testing, and clinical trials. The approval processes by regulatory agencies such as the FDA or EMA can be lengthy and costly. Ensuring compliance with these regulations is essential for market entry and for maintaining product quality, which can delay or accelerate time to market.

What are the technological developments shaping the upstream of this market?

Technological developments in device miniaturization, smart technology integration (such as dose monitoring), and the enhancement of drug formulations are shaping the upstream landscape. New innovations in bioavailability and drug absorption methods through the nasal route are critical to improving device efficacy. Advancements in materials science also allow for better, more sustainable device production, which impacts upstream activities.

What are the key factors in the midstream of the intranasal drug delivery devices market?

Key factors in the midstream include the manufacturing processes, assembly of devices, quality control, and packaging. Efficient production techniques, along with effective scaling from prototype to mass production, are essential for meeting market demand. Additionally, ensuring the devices meet regulatory standards during production is critical for compliance and safety.

How do distribution channels affect the intranasal drug delivery devices market?

Distribution channels play a significant role in delivering intranasal drug delivery devices to end-users, including healthcare providers and patients. These channels must be optimized for efficiency and reach, ensuring timely delivery while maintaining product integrity. Partnerships with distributors, hospitals, pharmacies, and e-commerce platforms also contribute to the market’s accessibility and overall growth.

What is the role of regulatory compliance in the midstream?

Regulatory compliance is essential in the midstream, ensuring that the intranasal drug delivery devices are manufactured according to industry standards and meet safety requirements. Compliance with regulations such as the FDA or EMA guidelines impacts the approval process, manufacturing procedures, and quality assurance systems, directly affecting the market's ability to scale and meet consumer demand.

How does pricing strategy influence the midstream?

Pricing strategy is crucial in the midstream as it directly impacts the cost of manufacturing, distribution, and profit margins. Balancing production costs with competitive pricing can make or break the market success of intranasal devices. Cost-effective manufacturing methods, while ensuring high-quality standards, are key to maintaining competitive pricing, particularly in the face of market expansion and competition.

What impact does competition have on the midstream in this market?

Competition influences the midstream by driving innovation in manufacturing processes and encouraging efficiencies in production. Companies must continuously improve their product offerings to remain competitive, which often leads to investments in advanced technologies, cost-reduction strategies, and faster delivery times. Additionally, the competitive landscape encourages companies to refine their supply chains, ensuring they can respond swiftly to market demands and regulatory challenges.

What are the key factors in the downstream of the intranasal drug delivery devices market?

Key factors in the downstream include customer adoption, product usage, and patient compliance. Once the devices are in the hands of healthcare providers and patients, ensuring ease of use, effectiveness, and safety becomes critical. Marketing and education efforts also play an important role in driving awareness and understanding of the benefits of intranasal drug delivery.

How do healthcare providers impact the downstream of this market?

Healthcare providers, including doctors and pharmacists, significantly influence the downstream by recommending intranasal drug delivery devices to patients. Their trust in the devices' efficacy and safety, along with their ability to educate patients, impacts adoption. Clinical trials and peer-reviewed studies also shape healthcare providers' willingness to embrace new drug delivery methods.

What is the role of patients in the downstream of this market?

Patients are at the core of the downstream market. Their preferences for non-invasive, easy-to-use treatments directly impact the demand for intranasal drug delivery devices. Patient satisfaction, based on comfort, effectiveness, and convenience, drives continued usage and influences healthcare decisions. Patient feedback can also guide future product improvements.

How does marketing influence the downstream in this market?

Marketing plays a significant role in educating both healthcare providers and patients about the benefits and availability of intranasal drug delivery devices. Effective marketing strategies can build brand loyalty and drive demand by emphasizing the device's advantages, such as ease of use, rapid drug absorption, and non-invasive nature. Awareness campaigns and product trials are often essential for widespread adoption.

What are the challenges in the downstream of the intranasal drug delivery devices market?

Challenges in the downstream include ensuring widespread adoption across diverse patient populations, overcoming skepticism, and addressing concerns about the effectiveness or safety of new devices. Market penetration can be slow in certain regions due to cultural preferences for traditional delivery methods, and ensuring consistent quality in user experience remains a key challenge. Additionally, patient education on device usage is essential for maintaining long-term adherence.

Chapter 1, to describe Intranasal Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intranasal Drug Delivery Devices, with price, sales, revenue and global market share of Intranasal Drug Delivery Devices from 2018 to 2023.
Chapter 3, the Intranasal Drug Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intranasal Drug Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intranasal Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intranasal Drug Delivery Devices.
Chapter 14 and 15, to describe Intranasal Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Intranasal Drug Delivery Devices
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Intranasal Drug Delivery Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Multidose
       1.3.3 Uni/bidose
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Intranasal Drug Delivery Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Personal Use
       1.4.3 Hospital Use
   1.5 Global Intranasal Drug Delivery Devices Market Size & Forecast
       1.5.1 Global Intranasal Drug Delivery Devices Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Intranasal Drug Delivery Devices Sales Quantity (2018-2029)
       1.5.3 Global Intranasal Drug Delivery Devices Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 BD
       2.1.1 BD Details
       2.1.2 BD Major Business
       2.1.3 BD Intranasal Drug Delivery Devices Product and Services
       2.1.4 BD Intranasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 BD Recent Developments/Updates
   2.2 AptarGroup
       2.2.1 AptarGroup Details
       2.2.2 AptarGroup Major Business
       2.2.3 AptarGroup Intranasal Drug Delivery Devices Product and Services
       2.2.4 AptarGroup Intranasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 AptarGroup Recent Developments/Updates
   2.3 3M
       2.3.1 3M Details
       2.3.2 3M Major Business
       2.3.3 3M Intranasal Drug Delivery Devices Product and Services
       2.3.4 3M Intranasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 3M Recent Developments/Updates
   2.4 Teleflex
       2.4.1 Teleflex Details
       2.4.2 Teleflex Major Business
       2.4.3 Teleflex Intranasal Drug Delivery Devices Product and Services
       2.4.4 Teleflex Intranasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Teleflex Recent Developments/Updates
   2.5 H＆T Presspart
       2.5.1 H＆T Presspart Details
       2.5.2 H＆T Presspart Major Business
       2.5.3 H＆T Presspart Intranasal Drug Delivery Devices Product and Services
       2.5.4 H＆T Presspart Intranasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 H＆T Presspart Recent Developments/Updates
   2.6 Bespak
       2.6.1 Bespak Details
       2.6.2 Bespak Major Business
       2.6.3 Bespak Intranasal Drug Delivery Devices Product and Services
       2.6.4 Bespak Intranasal Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Bespak Recent Developments/Updates

3 Competitive Environment: Intranasal Drug Delivery Devices by Manufacturer

   3.1 Global Intranasal Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Intranasal Drug Delivery Devices Revenue by Manufacturer (2018-2023)
   3.3 Global Intranasal Drug Delivery Devices Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Intranasal Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Intranasal Drug Delivery Devices Manufacturer Market Share in 2022
       3.4.2 Top 6 Intranasal Drug Delivery Devices Manufacturer Market Share in 2022
   3.5 Intranasal Drug Delivery Devices Market: Overall Company Footprint Analysis
       3.5.1 Intranasal Drug Delivery Devices Market: Region Footprint
       3.5.2 Intranasal Drug Delivery Devices Market: Company Product Type Footprint
       3.5.3 Intranasal Drug Delivery Devices Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Intranasal Drug Delivery Devices Market Size by Region
       4.1.1 Global Intranasal Drug Delivery Devices Sales Quantity by Region (2018-2029)
       4.1.2 Global Intranasal Drug Delivery Devices Consumption Value by Region (2018-2029)
       4.1.3 Global Intranasal Drug Delivery Devices Average Price by Region (2018-2029)
   4.2 North America Intranasal Drug Delivery Devices Consumption Value (2018-2029)
   4.3 Europe Intranasal Drug Delivery Devices Consumption Value (2018-2029)
   4.4 Asia-Pacific Intranasal Drug Delivery Devices Consumption Value (2018-2029)
   4.5 South America Intranasal Drug Delivery Devices Consumption Value (2018-2029)
   4.6 Middle East and Africa Intranasal Drug Delivery Devices Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2029)
   5.2 Global Intranasal Drug Delivery Devices Consumption Value by Type (2018-2029)
   5.3 Global Intranasal Drug Delivery Devices Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2029)
   6.2 Global Intranasal Drug Delivery Devices Consumption Value by Application (2018-2029)
   6.3 Global Intranasal Drug Delivery Devices Average Price by Application (2018-2029)

7 North America

   7.1 North America Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2029)
   7.2 North America Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2029)
   7.3 North America Intranasal Drug Delivery Devices Market Size by Country
       7.3.1 North America Intranasal Drug Delivery Devices Sales Quantity by Country (2018-2029)
       7.3.2 North America Intranasal Drug Delivery Devices Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2029)
   8.2 Europe Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2029)
   8.3 Europe Intranasal Drug Delivery Devices Market Size by Country
       8.3.1 Europe Intranasal Drug Delivery Devices Sales Quantity by Country (2018-2029)
       8.3.2 Europe Intranasal Drug Delivery Devices Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Intranasal Drug Delivery Devices Market Size by Region
       9.3.1 Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Intranasal Drug Delivery Devices Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2029)
   10.2 South America Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2029)
   10.3 South America Intranasal Drug Delivery Devices Market Size by Country
       10.3.1 South America Intranasal Drug Delivery Devices Sales Quantity by Country (2018-2029)
       10.3.2 South America Intranasal Drug Delivery Devices Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Intranasal Drug Delivery Devices Market Size by Country
       11.3.1 Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Intranasal Drug Delivery Devices Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Intranasal Drug Delivery Devices Market Drivers
   12.2 Intranasal Drug Delivery Devices Market Restraints
   12.3 Intranasal Drug Delivery Devices Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Intranasal Drug Delivery Devices and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Intranasal Drug Delivery Devices
   13.3 Intranasal Drug Delivery Devices Production Process
   13.4 Intranasal Drug Delivery Devices Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Intranasal Drug Delivery Devices Typical Distributors
   14.3 Intranasal Drug Delivery Devices Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Intranasal Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Intranasal Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. BD Basic Information, Manufacturing Base and Competitors
   Table 4. BD Major Business
   Table 5. BD Intranasal Drug Delivery Devices Product and Services
   Table 6. BD Intranasal Drug Delivery Devices Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. BD Recent Developments/Updates
   Table 8. AptarGroup Basic Information, Manufacturing Base and Competitors
   Table 9. AptarGroup Major Business
   Table 10. AptarGroup Intranasal Drug Delivery Devices Product and Services
   Table 11. AptarGroup Intranasal Drug Delivery Devices Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. AptarGroup Recent Developments/Updates
   Table 13. 3M Basic Information, Manufacturing Base and Competitors
   Table 14. 3M Major Business
   Table 15. 3M Intranasal Drug Delivery Devices Product and Services
   Table 16. 3M Intranasal Drug Delivery Devices Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. 3M Recent Developments/Updates
   Table 18. Teleflex Basic Information, Manufacturing Base and Competitors
   Table 19. Teleflex Major Business
   Table 20. Teleflex Intranasal Drug Delivery Devices Product and Services
   Table 21. Teleflex Intranasal Drug Delivery Devices Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Teleflex Recent Developments/Updates
   Table 23. H＆T Presspart Basic Information, Manufacturing Base and Competitors
   Table 24. H＆T Presspart Major Business
   Table 25. H＆T Presspart Intranasal Drug Delivery Devices Product and Services
   Table 26. H＆T Presspart Intranasal Drug Delivery Devices Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. H＆T Presspart Recent Developments/Updates
   Table 28. Bespak Basic Information, Manufacturing Base and Competitors
   Table 29. Bespak Major Business
   Table 30. Bespak Intranasal Drug Delivery Devices Product and Services
   Table 31. Bespak Intranasal Drug Delivery Devices Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Bespak Recent Developments/Updates
   Table 33. Global Intranasal Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023) & (M Units)
   Table 34. Global Intranasal Drug Delivery Devices Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 35. Global Intranasal Drug Delivery Devices Average Price by Manufacturer (2018-2023) & (USD/Unit)
   Table 36. Market Position of Manufacturers in Intranasal Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 37. Head Office and Intranasal Drug Delivery Devices Production Site of Key Manufacturer
   Table 38. Intranasal Drug Delivery Devices Market: Company Product Type Footprint
   Table 39. Intranasal Drug Delivery Devices Market: Company Product Application Footprint
   Table 40. Intranasal Drug Delivery Devices New Market Entrants and Barriers to Market Entry
   Table 41. Intranasal Drug Delivery Devices Mergers, Acquisition, Agreements, and Collaborations
   Table 42. Global Intranasal Drug Delivery Devices Sales Quantity by Region (2018-2023) & (M Units)
   Table 43. Global Intranasal Drug Delivery Devices Sales Quantity by Region (2024-2029) & (M Units)
   Table 44. Global Intranasal Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
   Table 45. Global Intranasal Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
   Table 46. Global Intranasal Drug Delivery Devices Average Price by Region (2018-2023) & (USD/Unit)
   Table 47. Global Intranasal Drug Delivery Devices Average Price by Region (2024-2029) & (USD/Unit)
   Table 48. Global Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2023) & (M Units)
   Table 49. Global Intranasal Drug Delivery Devices Sales Quantity by Type (2024-2029) & (M Units)
   Table 50. Global Intranasal Drug Delivery Devices Consumption Value by Type (2018-2023) & (USD Million)
   Table 51. Global Intranasal Drug Delivery Devices Consumption Value by Type (2024-2029) & (USD Million)
   Table 52. Global Intranasal Drug Delivery Devices Average Price by Type (2018-2023) & (USD/Unit)
   Table 53. Global Intranasal Drug Delivery Devices Average Price by Type (2024-2029) & (USD/Unit)
   Table 54. Global Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2023) & (M Units)
   Table 55. Global Intranasal Drug Delivery Devices Sales Quantity by Application (2024-2029) & (M Units)
   Table 56. Global Intranasal Drug Delivery Devices Consumption Value by Application (2018-2023) & (USD Million)
   Table 57. Global Intranasal Drug Delivery Devices Consumption Value by Application (2024-2029) & (USD Million)
   Table 58. Global Intranasal Drug Delivery Devices Average Price by Application (2018-2023) & (USD/Unit)
   Table 59. Global Intranasal Drug Delivery Devices Average Price by Application (2024-2029) & (USD/Unit)
   Table 60. North America Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2023) & (M Units)
   Table 61. North America Intranasal Drug Delivery Devices Sales Quantity by Type (2024-2029) & (M Units)
   Table 62. North America Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2023) & (M Units)
   Table 63. North America Intranasal Drug Delivery Devices Sales Quantity by Application (2024-2029) & (M Units)
   Table 64. North America Intranasal Drug Delivery Devices Sales Quantity by Country (2018-2023) & (M Units)
   Table 65. North America Intranasal Drug Delivery Devices Sales Quantity by Country (2024-2029) & (M Units)
   Table 66. North America Intranasal Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
   Table 67. North America Intranasal Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
   Table 68. Europe Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2023) & (M Units)
   Table 69. Europe Intranasal Drug Delivery Devices Sales Quantity by Type (2024-2029) & (M Units)
   Table 70. Europe Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2023) & (M Units)
   Table 71. Europe Intranasal Drug Delivery Devices Sales Quantity by Application (2024-2029) & (M Units)
   Table 72. Europe Intranasal Drug Delivery Devices Sales Quantity by Country (2018-2023) & (M Units)
   Table 73. Europe Intranasal Drug Delivery Devices Sales Quantity by Country (2024-2029) & (M Units)
   Table 74. Europe Intranasal Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
   Table 75. Europe Intranasal Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
   Table 76. Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2023) & (M Units)
   Table 77. Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity by Type (2024-2029) & (M Units)
   Table 78. Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2023) & (M Units)
   Table 79. Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity by Application (2024-2029) & (M Units)
   Table 80. Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity by Region (2018-2023) & (M Units)
   Table 81. Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity by Region (2024-2029) & (M Units)
   Table 82. Asia-Pacific Intranasal Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
   Table 83. Asia-Pacific Intranasal Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
   Table 84. South America Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2023) & (M Units)
   Table 85. South America Intranasal Drug Delivery Devices Sales Quantity by Type (2024-2029) & (M Units)
   Table 86. South America Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2023) & (M Units)
   Table 87. South America Intranasal Drug Delivery Devices Sales Quantity by Application (2024-2029) & (M Units)
   Table 88. South America Intranasal Drug Delivery Devices Sales Quantity by Country (2018-2023) & (M Units)
   Table 89. South America Intranasal Drug Delivery Devices Sales Quantity by Country (2024-2029) & (M Units)
   Table 90. South America Intranasal Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
   Table 91. South America Intranasal Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
   Table 92. Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity by Type (2018-2023) & (M Units)
   Table 93. Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity by Type (2024-2029) & (M Units)
   Table 94. Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity by Application (2018-2023) & (M Units)
   Table 95. Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity by Application (2024-2029) & (M Units)
   Table 96. Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity by Region (2018-2023) & (M Units)
   Table 97. Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity by Region (2024-2029) & (M Units)
   Table 98. Middle East & Africa Intranasal Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
   Table 99. Middle East & Africa Intranasal Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
   Table 100. Intranasal Drug Delivery Devices Raw Material
   Table 101. Key Manufacturers of Intranasal Drug Delivery Devices Raw Materials
   Table 102. Intranasal Drug Delivery Devices Typical Distributors
   Table 103. Intranasal Drug Delivery Devices Typical Customers

List of Figures

   Figure 1. Intranasal Drug Delivery Devices Picture
   Figure 2. Global Intranasal Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Intranasal Drug Delivery Devices Consumption Value Market Share by Type in 2022
   Figure 4. Multidose Examples
   Figure 5. Uni/bidose Examples
   Figure 6. Global Intranasal Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 7. Global Intranasal Drug Delivery Devices Consumption Value Market Share by Application in 2022
   Figure 8. Personal Use Examples
   Figure 9. Hospital Use Examples
   Figure 10. Global Intranasal Drug Delivery Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 11. Global Intranasal Drug Delivery Devices Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 12. Global Intranasal Drug Delivery Devices Sales Quantity (2018-2029) & (M Units)
   Figure 13. Global Intranasal Drug Delivery Devices Average Price (2018-2029) & (USD/Unit)
   Figure 14. Global Intranasal Drug Delivery Devices Sales Quantity Market Share by Manufacturer in 2022
   Figure 15. Global Intranasal Drug Delivery Devices Consumption Value Market Share by Manufacturer in 2022
   Figure 16. Producer Shipments of Intranasal Drug Delivery Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 17. Top 3 Intranasal Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
   Figure 18. Top 6 Intranasal Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
   Figure 19. Global Intranasal Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
   Figure 20. Global Intranasal Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
   Figure 21. North America Intranasal Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
   Figure 22. Europe Intranasal Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
   Figure 23. Asia-Pacific Intranasal Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
   Figure 24. South America Intranasal Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
   Figure 25. Middle East & Africa Intranasal Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
   Figure 26. Global Intranasal Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 27. Global Intranasal Drug Delivery Devices Consumption Value Market Share by Type (2018-2029)
   Figure 28. Global Intranasal Drug Delivery Devices Average Price by Type (2018-2029) & (USD/Unit)
   Figure 29. Global Intranasal Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 30. Global Intranasal Drug Delivery Devices Consumption Value Market Share by Application (2018-2029)
   Figure 31. Global Intranasal Drug Delivery Devices Average Price by Application (2018-2029) & (USD/Unit)
   Figure 32. North America Intranasal Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 33. North America Intranasal Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 34. North America Intranasal Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
   Figure 35. North America Intranasal Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
   Figure 36. United States Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 37. Canada Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 38. Mexico Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Europe Intranasal Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 40. Europe Intranasal Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 41. Europe Intranasal Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
   Figure 42. Europe Intranasal Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
   Figure 43. Germany Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 44. France Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 45. United Kingdom Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. Russia Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. Italy Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 49. Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 50. Asia-Pacific Intranasal Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
   Figure 51. Asia-Pacific Intranasal Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
   Figure 52. China Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 53. Japan Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 54. Korea Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. India Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Southeast Asia Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Australia Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. South America Intranasal Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 59. South America Intranasal Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 60. South America Intranasal Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
   Figure 61. South America Intranasal Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
   Figure 62. Brazil Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 63. Argentina Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 64. Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 65. Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 66. Middle East & Africa Intranasal Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
   Figure 67. Middle East & Africa Intranasal Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
   Figure 68. Turkey Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 69. Egypt Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 70. Saudi Arabia Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. South Africa Intranasal Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Intranasal Drug Delivery Devices Market Drivers
   Figure 73. Intranasal Drug Delivery Devices Market Restraints
   Figure 74. Intranasal Drug Delivery Devices Market Trends
   Figure 75. Porters Five Forces Analysis
   Figure 76. Manufacturing Cost Structure Analysis of Intranasal Drug Delivery Devices in 2022
   Figure 77. Manufacturing Process Analysis of Intranasal Drug Delivery Devices
   Figure 78. Intranasal Drug Delivery Devices Industrial Chain
   Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 80. Direct Channel Pros & Cons
   Figure 81. Indirect Channel Pros & Cons
   Figure 82. Methodology
   Figure 83. Research Process and Data Source